Novel Treatment for Diabetes- Focusing on GLP-1 and SGLT2 (posters) (posters)

FRI 708

Dapagliflozin As Additional Treatment to Liraglutide and Insulin in Patients with Type 1 Diabetes. Randomized Clinical Trial of 12 Weeks
Nitesh D Kuhadiya, Aditya Mehta, Husam Ghanim, Manisha Garg, Jeanne Hejna, Antoine Makdissi, Ajay Chaudhuri, Manav Batra and Paresh Dandona

FRI 709

Unexpected Expression of Glucagon-like Peptide-1 Receptor in Papillary Thyroid Carcinomas : Another Consideration during Incretin Based Therapy
Su Kyoung Kwon, Bu Kyung Kim, Young-Sik Choi, So Young Ock, Min Jung Jung, Jeonghoon Heo, Jeong Hoon Kim and Sookja Kim

FRI 710

Effect of Once-Weekly Subcutaneous Treatment with Semaglutide, a GLP-1 Analog, on Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects
Helene Hausner, Thomas William Anderson, Julie Derving Karsbøl, Anders Gaarsdal Holst, Jacob Bonde Jacobsen, Frank Wagner and Georg Golor

FRI 711

Effect of Exenatide Once Weekly on Quality of Glycemic Control in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Juan Pablo Frías, James A Ruggles, Sergey Zhuplatov, Samer Nakhle, Eric Klein, John Pullman, Rong Zhou and Poul Strange

FRI 712

Lixisenatide Therapy in Older Patients with Type 2 Diabetes Inadequately Controlled on Their Current Anti-Diabetic Treatment: The Getgoal-O Study (NCT01798706)
Graydon S Meneilly, Hasan Alawi, George E Dailey III, Carlos Trescoli, Helard Manrique Hurtado, Hailing Guo, Christine Roy-Duval, Valerie Pilorget, Riccardo Perfetti and Hamish Simpson

FRI 716

Efficacy and Safety of Gemigliptin/Metformin Initial Combination Therapy Versus Either As Monotherapy in Drug-Naïve Patients with Type 2 Diabetes
Soo Lim, Kyungwan MIN, JaeMyung Yu, Parinya Chamnan, Eun Sook Kim, Kun-Ho Yoon, Sam Kwon, Min Kyong Moon, Kwan Woo Lee, Dong-Jun Kim, Mikyung Kim, Manaj Wongtanate, Eun Young Kim, Sung-Ho Kim and Moon-Kyu Lee

FRI 717

HbA1c Changes with Empagliflozin/Linagliptin Are Independent of Baseline Age in Subjects with Type 2 Diabetes
Jochen R Seufert, Sanjay Patel, Egon Pfarr, Angelo Del Parigi and Christopher Lee

FRI 718

Triple Therapy with Saxagliptin Add-on to Dapagliflozin Plus Metformin: Characterization of the Open-Label Lead-in Period of a Phase 3 Trial
Stephan Matthaei, Aleksander Celinski, Doina Catrinoiu, Lars Hansen, Hungta Chen, Ricardo Garcia-Sanchez, Alex Chin and Nayyar Iqbal